Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine.

Lallemant, M; Ngo-Giang-Huong, N; Jourdain, G; Traisaithit, P; Cressey, TR; Collins, IJ; Jarupanich, T; Sukhumanant, T; Achalapong, J; Sabsanong, P; +18 more... Chotivanich, N; Winiyakul, N; Ariyadej, S; Kanjanasing, A; Ratanakosol, J; Hemvuttiphan, J; Kengsakul, K; Wannapira, W; Sittipiyasakul, V; Pornkitprasarn, W; Liampongsabuddhi, P; McIntosh, K; Van Dyke, RB; Frenkel, LM; Koetsawang, S; Le Coeur, S; Kanchana, S; PHPT-4 Study Team; (2010) Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine. Clinical infectious diseases, 50 (6). pp. 898-908. ISSN 1058-4838 DOI: https://doi.org/10.1086/650745

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1086/650745

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar